Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's DiseaseCatherine M. Bollard, Helen E. Heslop, M. Helen Huls et al.|The Journal of Experimental Medicine|2004Cited by 390
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphomaChristiane Pott, Michael Kneba, Carsten Schrader et al.|Blood|2005Cited by 162